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Abstract
Background: Invasive Aspergillus infections are frequently seen in immunocompromised patients
but arthritis is a rare complication of Aspergillus infections in the absence of immune suppressive
therapy, trauma or surgical intervention.
Case presentation: A 17 years old male patient with arthritis and patellar osteomyelitis of the
left knee whose further investigations revealed chronic granulomatous disease as the underlying
disease is followed. Aspergillus fumigatus was isolated from the synovial fluid and the tissue samples
cultures. He was treated with Amphotericin B deoxicolate 0.7 mg/kg/day. Also surgical
debridement was performed our patient. Amphotericin B nephrotoxicity developed and the
therapy switched to itraconazole 400 mg/day. Itraconazole therapy were discontinued at the 6th
month. He can perform all the activities of daily living including.
Conclusion: We think that, chronic granulomatous disease should be investigated in patients who
have aspergillar arthritis and osteomyelitis.
Background
Aspergillus causes of infection in immunocompromised
patients. In aspergillar arthritis, the immune system is
found to be defective frequently. Chronic granulomatous
disease (CGD) is the major underlying disease [1]. CGD is
a 70 % X-linked recessive disease effecting especially the
male patients and characterized by the impaired phago-
cyte microbicidal activity. Bacterial and fungal infections
often begin during infancy and recur throughout child-
hood and adolescence [2–5].
Case Presentation
A 17 years old male patient referring to a private medical
clinic with an arthritis at his left knee was given non ster-
oidal anti-inflammatory therapy. As his arthritis contin-
ued, he was admitted to our hospital. In 1988, he had a
craniotomy and a cerebral mass was excised but he had no
further pathology reports concerning the excised material
and he was continuing to take antiepileptic medications.
In 1994 for pulmonary tbc, he had been given antituber-
culosis therapy for one year. He had no trauma or surgical
intervention to his left knee. In his physical examination,
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his body temperature was 39.2°C, multiple lymphaden-
opathy with different sizes at the axillar region, hepat-
osplenomegaly and arthritis at his left knee was detected.
Laboratory examination revealed erythrocyte sedimenta-
tion rate (ESR) 86 mm/h, hemoglobin 9.5 gr/dl, leukocyte
5900 /mm3, thrombocyte 473 000/m3, CRP 221 mg/dl
(normal < 5 mg/dl), Ig G 20.9 g/l (normal 7–16 g/l), Ig A
5.5 g/l (normal 0.7–4 g/l), Ig M 2.8 g/l (normal 0.4–2.3 g/
l), albumin 24 mg/dl (normal > 35 mg/dl), PPD 20 mm
diameter and HIV, rheumatoid factor and brucella agglu-
tination tests were all negative. All the other biochemical
tests were normal. X rays and magnetic resonance imaging
(MRI) of the left joint showed septic arthritis (Figure 1)
and patellar osteomyelitis (Figure 2). As the synovial fluid
analysis displayed 80 % polymorphonuclear leukocytes,
ceftriaxone 2 g/day and teicoplanin 400 mg/day were in-
titiated with the diagnosis of septic arthritis. His cranial
MRI was normal except secondary findings due to his pre-
vious cranial operation. In the computerized tomography
(CT) of the thoracal region, there were multiple lymph
nodes at the axillary region and multiple calcified lymph
nodes at the hilar region but bilateral pulmonary
paranchimal regions were normal. The results of the
blood cultures were negative. At the examination of syno-
vial fluid, AARB was negative. Aspergillus fumigatus was
isolated from the synovial fluid. Excisionel biopsies were
taken from the left knee synovium and axillary lymph
node. Histopathological examination of the left knee
specimen expressed granulomatous lesion due to Aspergil-
lus (Figure 3) and the lymph node biopsy from the axillary
region showed changes compatible with the granuloma-
tous disease. The patellar osteomyelitic tissue was surgi-
Figure 1
Left knee radiograph for patient with Aspergillus arthritis and osteomyelitis. A lytic lesion of the patella.Annals of Clinical Microbiology and Antimicrobials 2003, 2 http://www.ann-clinmicrob.com/content/2/1/2
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cally excised and another synovial fluid sample was taken
from the left knee at the same session. From the tissue
samples cultures Aspergillus fumigatus were yielded. Antibi-
otic treatment switched to Amphotericin B deoxicolate 0.7
mg/kg/day. G6PD level were normal. As the nitroblue
tetrazolium test (NBT) was positive, the patient was diag-
nosed as chronic granulomatous disease. Surgical debri-
dement was performed. On the 37 th day at the total
dosage of 820 mg of amphotericin B nephrotoxicity devel-
oped and the therapy switched to itraconazole 400 mg/
day. The infection was treated with surgical debridement
and antifungal treatment. At the 37th day, ESR decreased
to 25 mm/h and CRP was <5 mg/dl. The surgical wound
healing was very slow and we could not introduce IFN-γ
because the licensed use of this preparation is not availa-
ble in our country. The patient was given co-trimoxazole
for prophylaxis and itraconazole therapy. As the surgical
wound healed, the co-trimoxazole prophylaxis and itraco-
nazole therapy were discontinued at the 6th month. The
limitation of the range of motion of the knee joint excel-
lently responded to physical therapy and rehabilitation
program that lasted three weeks and a knee joint flexion
of 90 degrees was achieved. The patient can perform all
the activities of daily living including the school activities
and he is not receiving any prophylactic medicine.
Discussion
Arthritis due to aspergillosis is a very rare condition. It can
result from the hematogeneous spread from the lungs to
the joints and it usually occurs in the setting of an immu-
nocompromised host. Predisposing conditions have been
described in the literature, such as chronic granulomatous
Figure 2
MRI scan showed left knee arthritis, osteomyelitis and fistulated patellar osteomyelitis.Annals of Clinical Microbiology and Antimicrobials 2003, 2 http://www.ann-clinmicrob.com/content/2/1/2
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disease, corticosteroid therapy, post-renal transplantation
and idiopathic thrombocytopenic purpura. However, in
immunocompetent patients, Aspergillus infection causing
arthritis or osteomyelitis usually occurs as an iatrogenic
infection after surgery [6]. Our patient did not have any
history of trauma or surgical intervention. Moreover, lack
of known any immune deficiency state or previous immu-
nosuppressive therapy makes us to think that CGD might
be predisposing factor.
Cohen et al. reviewed the records of 245 patients with
CGD and found that 20% had a history of fungal infec-
tion and Aspergillus accounted for 78% of the fungal infec-
tions. Invasive Aspergillus infection in patients with CGD
is associated with mortality rates approaching to 50% [7].
Liese et al evaluated the records of 39 patients with CGD
and they stated that infections with Aspergillus  species
have become the major cause of infectious complications
and death and among the pneumonia episodes besides
Candida species and Pseudomonas aeruginosa, Aspergillus spe-
cies were the most frequently isolated microorganisms in
patients with CGD [8].
CGD is an 70% X-linked recessive disorder of phagocyte
function, in which the phagocytes were unable to generate
super oxide anions and other microbicidal oxygen metab-
olites, resulting in increased susceptibility to infection
with a wide variety of bacterial and fungal pathogens
[3,5,9,10]. These patients have an inherited phagocyte-
killing defect that occurs as a result of biochemical abnor-
malities in the NADHP oxidase system [9,10].
The most characteristic pathogens are catalase-positive
microorganisms or microorganisms that can not generate
hydrogen peroxide. Catalase negative organisms such as
Streptococci are normally killed by the phagositic cells of
the patients but microorganisms such as S. aureus, S. epi-
dermitis, E. coli, S. marcescens, Klebsiella, Pseudomonas, B.
cepecia, Proteus, Salmonella, C. albicans can not be eliminat-
ed. Localized and disseminated M. tuberculosis and  As-
pergillus infections were also commonly seen [2,5,9,10].
Figure 3
The synovial biopsy of the left knee expressed granulomatous lession due to Aspergillus.Annals of Clinical Microbiology and Antimicrobials 2003, 2 http://www.ann-clinmicrob.com/content/2/1/2
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Infections may be acute, subacute or chronic. Besides the
delay of tissue healing, acute and chronic inflammatory
response may be slow and there may be also a granuloma
formation [2,4]. CGD is commonly associated with der-
matitis, lymphadenitis, enlargement of liver, spleen and
growth retardation [2,3]. The physical examination of our
patient also revealed hepatosplenomegaly, axillar multi-
ple lymphadenopathy and retardation of normal growth
and development.
These phagocytes unlike normal phagocytes, fail to reduce
the histochemical dye nitroblue tetrazolium (NBT) to a
blue-black deposit after stimulation with endo-toxin or
phorbol myristate acetate. Definite diagnosis can be estab-
lished by the NBT test [2,5,11] which was also positive in
our patient. The normal G6PD levels in our patient make
us to think that this is not the autosomal recessive form of
this disease. Although the diagnosis of CGD is established
at 17 years of age, active Tbc infection when he was 9 years
old and a craniotomy operation (probably because of
granuloma) and retardation of growth and development
shows that our patient has a mild form of CGD for a long
time. As we could not reach the biopsy specimen records
of the craniotomy operation of the patient when he was
three years old, we can not say anything about the nature
of the tissue, whether it was due to aspergillus or not. In
addition, diagnosis and specific therapy of Tbc were per-
formed in an Education and Research hospital specially
dealing with Tbc patients and at this point, we feel confi-
dent about the diagnosis of our patient.
Treatment of the arthritis due to Aspergillus infection espe-
cially needs surgical drainage. The main difference of
these lesions was commonly encountered granulomatous
masses. A surgical incision and drainage was performed to
our patient's knee joint and the obtained synovial tissue
biopsy specimen consisted of granulomatous tissue. Only
two antifungal agents which have activity against Aspergil-
lus are licensed-amphotericin B and itraconazole [12]. For
the treatment of Aspergillus osteomyelitis, early surgical
debridement and amphotericin B is recommended. How-
ever, because of the risk of nephrotoxicity the maximum
dosage should be 3 grams and the maximum duration of
therapy should be 12 weeks [6]. Oral or intravenous itra-
conazole is a safe and well tolerated agent for the treat-
ment of invasive Aspergillosis  [13]. In one case report,
itraconazole was used for one year after surgical debri-
ment of the osteomyelitis and resulted clinical recovery
[14]. Tsumura et al. reported that the initial treatment
consisting of surgical debridement and antibiotic therapy
with amphotericin B, itraconazole and flucytosine did not
control the infection but after administering recombinant
IFN-γ it was found to be effective in controlling the course
of severe invasive Aspergillosis [15]. For the treatment of
Aspergillus arthritis, Steinfeld et al. performed an arthro-
scopic debridement and administered intravenous am-
photericin B (60 mg iv every 48 hours) over a 6 week
period and oral itraconazole (600 mg daily) for 9 months.
The follow-up of the patient revealed very good results
without evidence of recurrence [16].
We could not find any report about the caspofungin ther-
apy in CGD in the English literature but we observed three
reports about the voriconazole, a large spectrum new tria-
zol, therapy in CGD. van't Hek et al successfully treated a
5 years old patient with CGD and Aspergillus nidulans
pneumonia with voriconazole in 10 weeks, which did not
respond to amphotericin therapy of 6 weeks [17]. Sevaux
et al observed clinical response at the second and
radiological response at the third month in an adult pa-
tient with CGD and Aspergillus fumigatus pneumonia with
voriconazole therapy [18]. In another study, treatment of
13 CGD children with voriconazole an initial dose 6 mg/
kg for the first day and then 4 mg/kg two times daily had
a success rate of 62% [19].
Conclusion
Without trauma or surgical intervention, arthritis and os-
teomyelitis due to Aspergillus cannot occur in healthy indi-
viduals. Encountering this situation must remind us an
immune system defect and the most common predispos-
ing factor for this defect is the CGD in otherwise normal
children, which should be searched.
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